TerminatedPhase 4ketamine

Reversal of Ketamine Pharmacodynamic Effects With Naloxone

Sponsored by Ullevaal University Hospital

NCT ID
NCT00921765
Target Enrollment
3 participants
Start Date
2009-12
Est. Completion
2017-12

About This Study

The purpose of this study is to determine whether the analgetic and other effects effect of ketamine are partly mediated through opioid receptors

Conditions Studied

Pain

Interventions

  • Saline
  • Saline + Ketamine
  • Naloxone + Placebo
  • Naloxone + Ketamine

Eligibility

Sex:FEMALE
Age:18 Years - 30 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Females of norwegian Caucasian origin who needs surgical removal of impacted third molars

Exclusion Criteria:

* Anamnestic information regarding psychiatric diagnosis regarding mother/father or brother/sister Concommitant medication other than oral contraceptives Hypersensitivity towards NSAID/opioids/study drugs Females with suspected or confirmed pregnancy Lactating females Surgery lasting more than 60 minutes

Study Locations (1)

Ullevaal University Hospital
Oslo, Norway

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source